Allan Friedman

Q: What Schools Are Affiliated With Allan Friedman

Allan Friedman is affiliated with the following schools: University of Melbourne, University of Chicago, Purdue University, Duke University

Allan Friedman's AcademicInfluence.com Rankings

Allan Friedman

Political Science

#1728

World Rank

#2043

Historical Rank

#837

USA Rank

Human Rights

#70

World Rank

#91

Historical Rank

#35

USA Rank

Public Policy

#136

World Rank

#139

Historical Rank

#94

USA Rank

political-science Degrees

Download Badge

Political Science

Allan Friedman's Degrees

Bachelors Political Science University of Chicago

Why Is Allan Friedman Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Allan Howard Friedman is the Guy L. Odom Professor of Neurological Surgery at Duke University Medical Center, specializing in tumor and vascular neurosurgery. He has been on the Duke faculty since 1981.

(See a Problem?)

Allan Friedman's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Comprehensive genomic characterization defines human glioblastoma genes and core pathways (2008) (5775)
IDH1 and IDH2 mutations in gliomas. (2009) (3013)
Bevacizumab plus irinotecan in recurrent glioblastoma multiforme. (2007) (1353)
TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal (2013) (1148)
Phase II Trial of Bevacizumab and Irinotecan in Recurrent Malignant Glioma (2007) (1067)
Phase II trial of gefitinib in recurrent glioblastoma. (2004) (747)
Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma. (2010) (715)
Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group. (1999) (654)
Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas (2012) (532)
Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma. (2006) (529)
Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. (1998) (523)
Recurrent Glioblastoma Treated with Recombinant Poliovirus (2018) (462)
Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas. (1991) (450)
DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma. (1998) (422)
PTEN gene mutations are seen in high-grade but not in low-grade gliomas. (1997) (403)
Subarachnoid hemorrhage from intracranial dissecting aneurysm. (1984) (377)
Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma. (2008) (363)
Irinotecan therapy in adults with recurrent or progressive malignant glioma. (1999) (363)
Cell surface localization and density of the tumor-associated variant of the epidermal growth factor receptor, EGFRvIII. (1997) (339)
Phase II study of imatinib mesylate plus hydroxyurea in adults with recurrent glioblastoma multiforme. (2005) (326)
Clinical Experience with α-Particle–Emitting 211At: Treatment of Recurrent Brain Tumor Patients with 211At-Labeled Chimeric Antitenascin Monoclonal Antibody 81C6 (2007) (320)
Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma. (2011) (318)
Fiber dissection technique: lateral aspect of the brain. (2000) (299)
Treatment of radiation‐induced nervous system injury with heparin and warfarin (1994) (290)
Simvastatin Reduces Vasospasm After Aneurysmal Subarachnoid Hemorrhage: Results of a Pilot Randomized Clinical Trial (2005) (278)
Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization. (1999) (276)
Phase II trial of temozolomide plus o6-benzylguanine in adults with recurrent, temozolomide-resistant malignant glioma. (2009) (273)
Tetanus toxoid and CCL3 improve DC vaccines in mice and glioblastoma patients (2015) (268)
Alterations of the TP53 gene in human gliomas. (1994) (266)
Phase II trial of murine (131)I-labeled antitenascin monoclonal antibody 81C6 administered into surgically created resection cavities of patients with newly diagnosed malignant gliomas. (2002) (262)
Phase I trial of temozolomide plus O6-benzylguanine for patients with recurrent or progressive malignant glioma. (2000) (259)
An epidermal growth factor receptor variant III–targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme (2009) (248)
Phase II trial of temozolomide in patients with progressive low-grade glioma. (2003) (243)
Progress Report of a Phase I Study of the Intracerebral Microinfusion of a Recombinant Chimeric Protein Composed of Transforming Growth Factor (TGF)-α and a Mutated form of the Pseudomonas Exotoxin Termed PE-38 (TP-38) for the Treatment of Malignant Brain Tumors (2003) (240)
Central nervous system cancers. (2005) (238)
Phase 2 trial of erlotinib plus sirolimus in adults with recurrent glioblastoma (2009) (226)
Epidermal growth factor receptor VIII peptide vaccination is efficacious against established intracerebral tumors. (2003) (226)
Poor drug distribution as a possible explanation for the results of the PRECISE trial. (2010) (224)
Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas (2014) (222)
Failed aneurysm surgery. Reoperation in 115 cases. (1984) (217)
Morphological Classification, Response to Therapy, and Survival in 263 Adult Patients With Acute Nonlymphoblastic Leukemia (1980) (214)
Phase I trial of O6-benzylguanine for patients undergoing surgery for malignant glioma. (1998) (212)
Acquired immunodeficiency syndrome (AIDS). (1987) (211)
Chromosome 10 deletion mapping in human gliomas: a common deletion region in 10q25. (1995) (207)
Surgical Management of Petroclival Meningiomas: Defining Resection Goals Based on Risk of Neurological Morbidity and Tumor Recurrence Rates in 137 Patients (2005) (203)
TOWNE-VACCINE-INDUCED PREVENTION OF CYTOMEGALOVIRUS DISEASE AFTER RENAL TRANSPLANTS (1984) (201)
Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study (2009) (199)
Seizure outcome after temporal lobectomy for temporal lobe epilepsy (2000) (197)
Preoperative functional MR imaging localization of language and motor areas: effect on therapeutic decision making in patients with potentially resectable brain tumors. (2006) (197)
Unarmed, tumor-specific monoclonal antibody effectively treats brain tumors. (2000) (196)
Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial results. (1998) (195)
Phase 1 Trial of Gefitinib Plus Sirolimus in Adults with Recurrent Malignant Glioma (2006) (193)
Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors. (2008) (188)
Phase II trial of carmustine plus O(6)-benzylguanine for patients with nitrosourea-resistant recurrent or progressive malignant glioma. (2002) (188)
Salvage radioimmunotherapy with murine iodine-131-labeled antitenascin monoclonal antibody 81C6 for patients with recurrent primary and metastatic malignant brain tumors: phase II study results. (2006) (186)
Brain tumors in mice are susceptible to blockade of epidermal growth factor receptor (EGFR) with the oral, specific, EGFR-tyrosine kinase inhibitor ZD1839 (iressa). (2002) (183)
Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination (2017) (176)
Bevacizumab Plus Irinotecan in Recurrent WHO Grade 3 Malignant Gliomas (2008) (174)
Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography (1991) (174)
Resistance to Tyrosine Kinase Inhibition by Mutant Epidermal Growth Factor Receptor Variant III Contributes to the Neoplastic Phenotype of Glioblastoma Multiforme (2004) (169)
Thrombin and hemin as central factors in the mechanisms of intracerebral hemorrhage-induced secondary brain injury and as potential targets for intervention. (2012) (159)
Posterior fossa arteriovenous malformations. (1986) (158)
CORRELATION OF SERUM BRAIN NATRIURETIC PEPTIDE WITH HYPONATREMIA AND DELAYED ISCHEMIC NEUROLOGICAL DEFICITS AFTER SUBARACHNOID HEMORRHAGE (2004) (156)
Drusen of the optic disc. A retrospective study in cadaver eyes. (1975) (156)
Exome sequencing identifies somatic gain-of-function PPM1D mutations in brainstem gliomas (2014) (152)
Leukocytosis as an independent risk factor for cerebral vasospasm following aneurysmal subarachnoid hemorrhage. (2003) (148)
Treatment of acute lymphoblastic leukemia in adults: results of the L-10 and L-10M protocols. (1983) (147)
Central nervous system cancers. (2011) (145)
Anterior temporal lobectomy for complex partial seizures (1990) (143)
Ultrastructure and clinicopathologic correlation of idiopathic preretinal macular fibrosis. (1975) (142)
The Addition of Bevacizumab to Standard Radiation Therapy and Temozolomide Followed by Bevacizumab, Temozolomide, and Irinotecan for Newly Diagnosed Glioblastoma (2011) (141)
INTRACEREBRAL INFUSATE DISTRIBUTION BY CONVECTION‐ENHANCED DELIVERY IN HUMANS WITH MALIGNANT GLIOMAS: DESCRIPTIVE EFFECTS OF TARGET ANATOMY AND CATHETER POSITIONING (2007) (141)
Influence of the type of surgery on the histologic diagnosis in patients with anaplastic gliomas (1991) (138)
2012 Young Investigator Award Winner: The Distribution of Body Mass as a Significant Risk Factor for Lumbar Spinal Fusion Postoperative Infections (2012) (134)
Phase I trial results of iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with newly diagnosed malignant gliomas. (2000) (132)
Bone marrow-derived dendritic cells pulsed with tumor homogenate induce immunity against syngeneic intracerebral glioma (2000) (129)
Use of the peak troponin value to differentiate myocardial infarction from reversible neurogenic left ventricular dysfunction associated with aneurysmal subarachnoid hemorrhage. (2003) (128)
Vestibular schwannomas in the modern era: epidemiology, treatment trends, and disparities in management. (2013) (128)
Phase II study of carboplatin, irinotecan, and bevacizumab for bevacizumab naïve, recurrent glioblastoma (2012) (127)
Effect of CYP3A-inducing anti-epileptics on sorafenib exposure: results of a phase II study of sorafenib plus daily temozolomide in adults with recurrent glioblastoma (2010) (127)
Loss of heterozygosity for 10q loci in human gliomas (1992) (126)
A review of VEGF/VEGFR-targeted therapeutics for recurrent glioblastoma. (2011) (124)
Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy (2009) (123)
Temozolomide in children with progressive low-grade glioma. (2007) (122)
Predictors of Outcome of Epilepsy Surgery: Multivariate Analysis with Validation (1996) (121)
Ganglioglioma: a clinical study with long-term follow-up. (1991) (121)
Phase II trial of irinotecan plus celecoxib in adults with recurrent malignant glioma (2005) (120)
Serum von Willebrand Factor, Matrix Metalloproteinase-9, and Vascular Endothelial Growth Factor Levels Predict the Onset of Cerebral Vasospasm after Aneurysmal Subarachnoid Hemorrhage (2002) (118)
Central nervous system cancers: Clinical Practice Guidelines in Oncology. (2005) (117)
Fractionated external-beam radiation therapy for meningiomas of the cavernous sinus. (1999) (114)
Temporal lobe hypometabolism on PET (1993) (114)
Clinical utility of a patient-specific algorithm for simulating intracerebral drug infusions. (2007) (114)
Dendritic Cells Pulsed with a Tumor-specific Peptide Induce Long-lasting Immunity and Are Effective against Murine Intracerebral Melanoma (2002) (113)
Neuronal migration disorders: Positron emission tomography correlations (1994) (112)
Monoclonal antibody blockade of IL-2 receptor α during lymphopenia selectively depletes regulatory T cells in mice and humans. (2011) (110)
Morphological classification, response to therapy, and survival in 263 adult patients with acute nonlymphoblastic leukemia. (1980) (109)
Phase II study of imatinib mesylate and hydroxyurea for recurrent grade III malignant gliomas (2007) (107)
A Pilot Study of IL-2Rα Blockade during Lymphopenia Depletes Regulatory T-cells and Correlates with Enhanced Immunity in Patients with Glioblastoma (2012) (105)
A Retrospective Analysis of a Remifentanil/Propofol General Anesthetic for Craniotomy Before Awake Functional Brain Mapping (2005) (104)
Seizure onset from periventricular nodular heterotopias (1998) (102)
Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival. (2016) (101)
Exercise behavior, functional capacity, and survival in adults with malignant recurrent glioma. (2011) (100)
The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma (2018) (100)
Central Nervous System Cancers, Version 1.2015. (2015) (99)
Impact of Tumor Histology on Resectability and Neurological Outcome in Primary Intramedullary Spinal Cord Tumors: A Single-Center Experience With 102 Patients (2011) (99)
Intrathecal 131I-labeled antitenascin monoclonal antibody 81C6 treatment of patients with leptomeningeal neoplasms or primary brain tumor resection cavities with subarachnoid communication: phase I trial results. (1996) (96)
A pilot study: 131I-antitenascin monoclonal antibody 81c6 to deliver a 44-Gy resection cavity boost. (2008) (95)
High-dose chemotherapy with autologous stem-cell rescue in children and adults with newly diagnosed pineoblastomas. (2003) (94)
Phase II study of metronomic chemotherapy with bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy (2011) (92)
MiR-215 Is Induced Post-transcriptionally via HIF-Drosha Complex and Mediates Glioma-Initiating Cell Adaptation to Hypoxia by Targeting KDM1B. (2016) (90)
Phase I trial of carmustine plus O6-benzylguanine for patients with recurrent or progressive malignant glioma. (2000) (88)
Dosimetry and radiographic analysis of 131I-labeled anti-tenascin 81C6 murine monoclonal antibody in newly diagnosed patients with malignant gliomas: a phase II study. (2005) (87)
Efficacy of intracerebral microinfusion of trastuzumab in an athymic rat model of intracerebral metastatic breast cancer. (2003) (85)
Nerve transposition for the restoration of elbow flexion following brachial plexus avulsion injuries. (1990) (85)
Bevacizumab continuation beyond initial bevacizumab progression among recurrent glioblastoma patients (2012) (84)
FDG-PET in the selection of brain lesions for biopsy. (1991) (84)
Quantitative analysis of O6-alkylguanine-DNA alkyltransferase in malignant glioma (2006) (84)
Phase 2 study of carboplatin, irinotecan, and bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy (2011) (83)
miR-33a promotes glioma-initiating cell self-renewal via PKA and NOTCH pathways. (2014) (83)
Ocular manifestations of multiple myeloma, Waldenström's macroglobulinemia and benign monoclonal gammopathy. (1981) (82)
Gliomas of the optic nerve: histological, immunohistochemical (MIB-1 and p53), and MRI analysis (2000) (82)
Thickness of subcutaneous fat as a risk factor for infection in cervical spine fusion surgery. (2013) (82)
Phase I studies of treatment of malignant gliomas and neoplastic meningitis with131I-radiolabeled monoclonal antibodies anti-tenascin 81C6 and anti-chondroitin proteoglycan sulfate Me1-14 F (ab′)2-a preliminary report (2005) (80)
Phase I study of Gliadel wafers plus temozolomide in adults with recurrent supratentorial high-grade gliomas. (2001) (80)
Phase II study of irinotecan (CPT-11) in children with high-risk malignant brain tumors: the Duke experience. (2002) (80)
Clinical and electrographic manifestations of lesional neocortical temporal lobe epilepsy (1997) (78)
Free Flap Reconstruction of the Scalp and Calvaria of Major Neurosurgical Resections in Cancer Patients: Lessons Learned Closing Large, Difficult Wounds of the Dura and Skull (2007) (78)
DREZ lesions for relief of pain related to spinal cord injury. (1986) (78)
Correlation of Hippocampal Neuronal Density and FDG‐PET in Mesial Temporal Lobe Epilepsy (1999) (77)
Contemporary Surgical Management of Vestibular Schwannomas: Analysis of Complications and Lessons Learned Over the Past Decade (2013) (77)
Phase I trial of irinotecan plus temozolomide in adults with recurrent malignant glioma (2005) (77)
Combined short- and long-term therapy for the treatment of cytomegalovirus retinitis using ganciclovir (BW B759U). (1987) (77)
Mismatch Repair Deficiency Does Not Mediate Clinical Resistance to Temozolomide in Malignant Glioma (2008) (76)
Topotecan treatment of adults with primary malignant glioma (1999) (76)
Addition of bevacizumab to standard radiation therapy and daily temozolomide is associated with minimal toxicity in newly diagnosed glioblastoma multiforme. (2012) (76)
Dorsal root entry zone lesions for the treatment of brachial plexus avulsion injuries: a follow-up study. (1988) (74)
Drusen of the optic disc. (1977) (74)
Cytomegalovirus retinitis: a manifestation of the acquired immune deficiency syndrome (AIDS). (1983) (73)
Central nervous system cancers, version 2.2014. Featured updates to the NCCN Guidelines. (2014) (73)
MRI-guided stereotactic biopsy in the diagnosis of glioma: comparison of biopsy and surgical resection specimen. (2003) (73)
Incidence and patterns of neuraxis metastases in children with diffuse pontine glioma★ (2006) (72)
Microsurgical management of 53 jugular foramen schwannomas: lessons learned incorporated into a modified grading system. (2008) (72)
Trigeminal Schwannomas: Skull Base Approaches and Operative Results in 105 Patients (2012) (72)
The genetic landscape of anaplastic astrocytoma (2013) (71)
Risk of cerebral vasopasm after subarachnoid hemorrhage reduced by statin therapy: A multivariate analysis of an institutional experience. (2006) (70)
Colocalization of Gadolinium-Diethylene Triamine Pentaacetic Acid With High-Molecular-Weight Molecules After Intracerebral Convection-Enhanced Delivery in Humans (2011) (69)
An outbreak of fungal endophthalmitis after intravitreal injection of compounded combined bevacizumab and triamcinolone. (2013) (69)
Morbidity and toxic effects associated with ganciclovir or foscarnet therapy in a randomized cytomegalovirus retinitis trial. Studies of ocular complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group. (1995) (68)
Ocular toxoplasmosis in AIDS patients. (1990) (67)
Fast Spin‐Echo, Magnetic Resonance Imaging‐Measured Hippocampal Volume: Correlation with Neuronal Density in Anterior Temporal Lobectomy Patients (1995) (67)
Complex partial seizures and mesial temporal sclerosis: evaluation with fast spin-echo MR imaging. (1993) (66)
Dendritic Cells Enhance Polyfunctionality of Adoptively Transferred T Cells That Target Cytomegalovirus in Glioblastoma. (2018) (66)
Temozolomide delivered by intracerebral microinfusion is safe and efficacious against malignant gliomas in rats. (2000) (66)
Ten-year experience with primary ocular 'reticulum cell sarcoma' (large cell non-Hodgkin's lymphoma). (1989) (66)
Dosimetry and dose-response relationships in newly diagnosed patients with malignant gliomas treated with iodine-131-labeled anti-tenascin monoclonal antibody 81C6 therapy. (2000) (65)
Regional treatment of epidermal growth factor receptor vIII-expressing neoplastic meningitis with a single-chain immunotoxin, MR-1. (1999) (64)
Comparison of intratumoral bolus injection and convection-enhanced delivery of radiolabeled antitenascin monoclonal antibodies. (2006) (64)
Critical Assessment of Operative Approaches for Hearing Preservation in Small Acoustic Neuroma Surgery: Retrosigmoid Vs Middle Fossa Approach (2010) (64)
Neuro-Behcet's disease (1995) (63)
Hearing preservation in surgery for large vestibular schwannomas. (2009) (63)
Delayed radiation necrosis of the optic nerve. (1973) (62)
Oncolytic polio virotherapy of cancer (2014) (60)
Bilateral Transpedicular Decompression and Harrington Rod Stabilization in the Management of Severe Thoracolumbar Burst Fractures (1992) (60)
Gait Abnormalities and Inflammatory Cytokines in an Autologous Nucleus Pulposus Model of Radiculopathy (2009) (59)
Urethan-induced retinopathy in pigmented rats. (1973) (59)
Dorsal root entry zone lesions in the treatment of pain following brachial plexus avulsion, spinal cord injury and herpes zoster. (1988) (59)
Molecular markers of prognosis in astrocytic tumors (2002) (58)
Sustained radiographic and clinical response in patient with bifrontal recurrent glioblastoma multiforme with intracerebral infusion of the recombinant targeted toxin TP-38: case study. (2005) (57)
Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy (2021) (57)
Comparative genetic patterns of glioblastoma multiforme: potential diagnostic tool for tumor classification. (2000) (57)
Dorsal root entry zone lesions for the treatment of postherpetic neuralgia. (1984) (56)
Distribution and dosimetry of I-123-labeled monoclonal antibody 81C6 in patients with anaplastic glioma. (1993) (56)
Retinal manifestations of the acquired immune deficiency syndrome (AIDS): cytomegalovirus, candida albicans, cryptococcus, toxoplasmosis and Pneumocystis carinii. (1983) (56)
Dorsal root entry zone lesions for intractable pain after trauma to the conus medullaris and cauda equina. (1995) (55)
Chemotherapy and novel therapeutic approaches in malignant glioma. (2005) (55)
Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 5. Clinical features of cytomegalovirus retinitis at diagnosis. Studies of ocular complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group. (1997) (54)
Long-term economic impact of coiling vs clipping for unruptured intracranial aneurysms. (2013) (54)
Worse outcomes for patients undergoing brain tumor and cerebrovascular procedures following the ACGME resident duty-hour restrictions. (2014) (54)
[18F]2-fluoro-2-deoxyglucose-positron emission tomography correlation of gadolinium-enhanced MR imaging of central nervous system neoplasia. (1993) (54)
Phase II Trial of Gliadel plus O6-Benzylguanine in Adults with Recurrent Glioblastoma Multiforme (2009) (54)
Surgical management of brainstem cavernomas: selection of approaches and microsurgical techniques (2010) (54)
Survival analysis of presumptive prognostic markers among oligodendrogliomas (2005) (53)
Dorsal root entry zone lesions for the treatment of post-herpetic neuralgia. (1984) (53)
Surgical approaches to pineal region tumors (2001) (52)
Tuberculoma of the choroid. (1980) (52)
An Injectable and In Situ-Gelling Biopolymer for Sustained Drug Release Following Perineural Administration (2008) (52)
Synthesis and characterization of a thermally-responsive tumor necrosis factor antagonist. (2008) (52)
Phase II trial of temozolomide (TMZ) plus irinotecan (CPT-11) in adults with newly diagnosed glioblastoma multiforme before radiotherapy (2009) (51)
Malignant peripheral nerve sheath tumor of the spine after radiation therapy for Hodgkin's lymphoma. (2004) (50)
The Effect of Propofol Versus Isoflurane Anesthesia on Human Cerebrospinal Fluid Markers of Alzheimer's Disease: Results of a Randomized Trial. (2016) (50)
Phase 2 trial of BCNU plus irinotecan in adults with malignant glioma. (2004) (49)
MR imaging in patients with temporal lobe seizures: correlation of results with pathologic findings. (1990) (48)
Microsurgical Management of Hypoglossal Schwannomas Over 3 Decades: A Modified Grading Scale to Guide Surgical Approach (2011) (48)
Tinzaparin prophylaxis against venous thromboembolic complications in brain tumor patients (2009) (48)
A histopathologic study of retinal arterial aneurysms. (1978) (47)
Prognostic value of magnetic resonance imaging-guided stereotactic biopsy in the evaluation of recurrent malignant astrocytoma compared with a lesion due to radiation effect. (2003) (46)
Solitary eosinophilic granuloma invading the clivus of an adult: case report. (1992) (46)
A Novel Method for Volumetric MRI Response Assessment of Enhancing Brain Tumors (2011) (46)
Novel human IgG2b/murine chimeric antitenascin monoclonal antibody construct radiolabeled with 131I and administered into the surgically created resection cavity of patients with malignant glioma: phase I trial results. (2006) (46)
Neurofibromatosis and neural crest neoplasms: primary acquired melanosis and malignant melanoma of the conjunctiva. (1989) (46)
An NMDA-mediated component of excitatory synaptic input to dentate granule cells in ‘epileptic’ human hippocampus studied in vitro (1990) (45)
Safety and pharmacokinetics of dose-intensive imatinib mesylate plus temozolomide: phase 1 trial in adults with malignant glioma. (2008) (44)
Fast spin-echo MR in hippocampal sclerosis: correlation with pathology and surgery. (1995) (44)
Treatment of spasmodic torticollis with intradural selective rhizotomies. (1993) (44)
A comprehensive analysis of 41 patients with rosette-forming glioneuronal tumors of the fourth ventricle (2013) (44)
Dosimetry of 131I-labeled 81C6 monoclonal antibody administered into surgically created resection cavities in patients with malignant brain tumors. (1999) (44)
Rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis: The foscarnet-ganciclovir cytomegalovirus retinitis trial (1997) (43)
Perioperative Management of Aneurysmal Subarachnoid Hemorrhage: Part 2. Postoperative Management (1995) (42)
Impact of Tumor Histology on Resectability and Neurological Outcome in Primary Intramedullary Spinal Cord Tumors: A Single-Center Experience With 102 Patients. (2015) (42)
Morbidity, mortality, and health care costs for patients undergoing spine surgery following the ACGME resident duty-hour reform: Clinical article. (2014) (42)
Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS: The cytomegalovirus retreatment trial (1996) (41)
Levetiracetam seizure prophylaxis in craniotomy patients at high risk for postoperative seizures (2013) (41)
A phase III randomized prospective trial of external beam radiotherapy, mitomycin C, carmustine, and 6-mercaptopurine for the treatment of adults with anaplastic glioma of the brain (1996) (40)
Molecular strategies for the treatment of malignant glioma—genes, viruses, and vaccines (2008) (40)
Intracranial atherosclerosis following radiotherapy (1988) (40)
Tumor-specific peptide vaccination in newly-diagnosed patients with GBM. (2006) (40)
Proton-beam irradiated epithelioid cell melanoma of the ciliary body. (1981) (39)
Drusen of the optic disc. A histopathological study. (1975) (39)
Assessment of physical functioning in recurrent glioma: preliminary comparison of performance status to functional capacity testing (2009) (39)
Conus medullaris nerve root avulsions. (1987) (38)
Senior-Loken syndrome (familial renal-retinal dystrophy) and Coats' disease. (1985) (38)
Late traumatic wound rupture following successful partial penetrating keratoplasty. (1973) (38)
Anatomical location dictating major surgical complications for intradural extramedullary spinal tumors: a 10-year single-institutional experience. (2013) (38)
fMRI activation mapping as a percentage of local excitation: Consistent presurgical motor maps without threshold adjustment (2009) (37)
Outcome and prognostic factors in adult cerebellar glioblastoma (2013) (37)
Metastatic Melanoma to the Spine Demographics, Risk Factors, and Prognosis in 114 Patients (1995) (36)
Phase I trial of temozolomide plus O6-benzylguanine 5-day regimen with recurrent malignant glioma. (2009) (35)
Treatment of neoplastic meningitis with intrathecal temozolomide. (1999) (35)
Craniocerebral plasmacytoma: MR features. (1997) (35)
Bilateral corneal dermoids. (1973) (35)
Jugular tubercle: Morphometric analysis and surgical significance. (2006) (35)
Quantitative assessment of cardiorespiratory fitness, skeletal muscle function, and body composition in adults with primary malignant glioma (2010) (35)
Malignant brainstem gliomas in adults: clinicopathological characteristics and prognostic factors (2014) (34)
Hearing preservation surgery for vestibular schwannomas via the retrosigmoid transmeatal approach: surgical tips (2014) (34)
Three-dimensional Computed Tomographic Cranial Base Measurements for Improvement of Surgical Approaches to the Petrous Carotid Artery and Apex Regions (2001) (34)
Surgical Outcome in Patients with Epilepsy with Occult Vascular Malformations Treated with Lesionectomy (1998) (34)
Calcifying Pseudoneoplasm of the Cerebellopontine Angle: Case Report (2011) (34)
Complications in the treatment of carpal tunnel syndrome. (1997) (34)
Low-grade astrocytomas: the prognostic value of fibrillary, gemistocytic, and protoplasmic tumor histology. (2013) (33)
MR imaging of thoracic extradural arachnoid cysts. (1988) (33)
Risk of Intracranial Aneurysms in Families With Subarachnoid Hemorrhage (1995) (33)
A case of Ollier's disease associated with two intracranial gliomas. (1987) (32)
Convection enhanced delivery of macromolecules for brain tumors. (2012) (32)
Bevacizumab, a monoclonal antibody to vascular endothelial growth factor (VEGF), and irinotecan for treatment of malignant gliomas. (2006) (31)
Impact of PhD training on scholarship in a neurosurgical career. (2014) (31)
Systemic antiviral drugs used in ophthalmology. (1992) (30)
The retinal lesions of the acquired immune deficiency syndrome. (1984) (30)
Patent foramen ovale as a possible risk factor for cryptogenic brain abscess : Report of two cases. Commentaries (2001) (30)
Management of tumor bed cysts after chemotherapeutic wafer implantation. Report of four cases. (2002) (30)
Manual of skull base dissection (2004) (29)
Simple identification of the third segment of the extracranial vertebral artery by extreme lateral inferior transcondylar-transtubercular exposure (ELITE) (2009) (29)
Cerebellopontine angle meningiomas: postoperative outcomes in a modern cohort. (2013) (29)
Utility of Three-dimensional Computed Tomographic Angiography for Assessment of Relationships between the Vertebrobasilar System and the Cranial Base (2001) (28)
Computerized assessment of vessel morphological changes during treatment of glioblastoma multiforme: Report of a case imaged serially by MRA over four years (2009) (28)
Ocular penetration of 5-fluorocytosine. (1978) (28)
Drug reservoirs in topical therapy. (1984) (28)
Retrosigmoid Suprafloccular Transhorizontal Fissure Approach for Resection of Brainstem Cavernous Malformation (2010) (28)
Outcome of Temporal Lobectomy in Adolescents (1996) (28)
The Effect of Propofol vs. Isoflurane Anesthesia on Postoperative Changes in Cerebrospinal Fluid Cytokine Levels: Results from a Randomized Trial (2017) (28)
Monitoring Radiographic Brain Tumor Progression (2011) (27)
Correlation Between Function and Structure in “Epileptic” Human Hippocampal Tissue Maintained In Vitro (1993) (27)
Prevalence, pathophysiology, and treatment of rhegmatogenous retinal detachment in treated cytomegalovirus retinitis. (1987) (27)
Reoperation in 115 cases (1984) (27)
Endogenous ocular aspergillosis. (1974) (26)
Photo atlas of skull base dissection (2009) (26)
Intraoperative floppy iris syndrome: report of a case and histopathologic analysis. (2010) (26)
New findings in the chromosome 13 long-arm deletion syndrome and retinoblastoma. (1979) (26)
Successfully treated postoperative Candida parakrusei endophthalmitis. (1973) (25)
Central nervous system cancers. (2011) (25)
Chemotherapy for adults with malignant glioma. (1999) (24)
Calcifying Pseudoneoplasms of the Skull Base Presenting with Cranial Neuropathies: Case Report and Literature Review (2012) (24)
Multiple dosing of prostaglandin F2 alpha or epinephrine on cynomolgus monkey eyes. III. Histopathology. (1988) (24)
Treatment of neuroinflammation by soluble tumor necrosis factor receptor Type II fused to a thermally responsive carrier. (2008) (24)
Neurotization of elements of the brachial plexus. (1991) (24)
Treatment of adults with progressive oligodendroglioma with carboplatin (CBDCA): preliminary results. Writing Committee for The Brain Tumor Center at Duke. (1998) (24)
External Ocular Pigmentation (1971) (24)
A novel, reproducible, and objective method for volumetric magnetic resonance imaging assessment of enhancing glioblastoma. (2014) (24)
Sugiura's sign. Perilimbal vitiligo in the Vogt-Koyanagi-Harada syndrome. (1981) (24)
The association of rubeosis iridis with endothelialisation of the anterior chamber: report of a clinical case with histopathological review of 16 additional cases. (1977) (24)
Clinicopathological characteristics and treatment of rhabdoid glioblastoma. (2013) (24)
Imaging of Convection Enhanced Delivery of Toxins in Humans (2011) (24)
Inhibitory simple partial (non-convulsive) status epilepticus after intracranial surgery (2000) (23)
Phase 1 trial of irinotecan plus BCNU in patients with progressive or recurrent malignant glioma. (2004) (23)
Evaluation of Variation in the Course of the Facial Nerve, Nerve Adhesion to Tumors, and Postoperative Facial Palsy in Acoustic Neuroma (2012) (23)
Skull base training and education using an artificial skull model created by selective laser sintering (2010) (23)
PRIMARY INTRAMEDULLARY MELANOCYTOMA OF THE SPINAL CORD: CASE REPORT (2009) (23)
Preauricular transzygomatic anterior infratemporal fossa approach for tumors in or around infratemporal fossa lesions (2012) (23)
Long term response in a patient with neoplastic meningitis secondary to melanoma treated with 131I‐radiolabeled antichondroitin proteoglycan sulfate Mel‐14 F(ab′)2 (2001) (22)
3-dimensional optimization of multiple arcs for stereotactic radiosurgery. (1993) (22)
Metastatic carcinoma of the iris. (1975) (22)
Changes in functional performance measures in adults undergoing chemoradiation for primary malignant glioma: a feasibility study. (2010) (22)
Squamous cell carcinoma of the conjunctiva. Value of exfoliative cytology in diagnosis. (1977) (22)
MTAP loss promotes stemness in glioblastoma and confers unique susceptibility to purine starvation. (2019) (22)
Subretinal neovascularisation in ocular toxoplasmosis. (1982) (22)
Patient survival on the dose escalation phase of the Oncolytic Polio/Rhinovirus Recombinant (PVSRIPO) against WHO grade IV malignant glioma (MG) clinical trial compared to historical controls. (2016) (21)
Cryptococcal meningitis in patients with glioma: a report of two cases (2008) (21)
Middle Fossa Approach for Total Resection of Petrous Apex Cholesterol Granulomas: Use of Vascularized Galeofascial Flap Preventing Recurrence (2013) (21)
Localized conjunctival amyloidosis: case reports and review of literature. (1986) (21)
Repair of isolated axillary nerve lesions after infraclavicular brachial plexus injuries: case reports. (1990) (21)
The association of retinitis pigmentosa with preretinal macular gliosis. (1977) (21)
A phase I trial of the farnesyl transferase inhibitor, SCH 66336, with temozolomide for patients with malignant glioma (2011) (20)
Radical anterior segment surgery for epithelial invasion of the anterior chamber: report of three cases. (1977) (20)
Clinical characteristics and treatment of malignant brainstem gliomas in elderly patients (2013) (20)
Impact of tumor histology on resectability and neurological outcome in primary intramedullary spinal cord tumors: a single-center experience with 102 patients. (2015) (19)
Long-term Survival in Glioblastoma with Cytomegalovirus pp 65-Targeted Vaccination (2017) (19)
Advanced Techniques in Image-Guided Brain and Spine Surgery. (2004) (19)
Marginal corneal ulceration (limbal guttering) as a presenting sign of temporal arteritis. (1980) (19)
Isolated Deep Ear Canal Pain: Possible Role of Auricular Branch of Vagus Nerve-Case Illustrations with Cadaveric Correlation. (2016) (19)
Surgical management of vestibular schwannomas after failed radiation treatment (2016) (19)
Morphometric three-dimensional computed tomography anatomy of the hypoglossal canal (2008) (18)
NEUROPHYSIOLOGICAL INTRAOPERATIVE MONITORING OF THE GLOSSOPHARYNGEAL NERVE: TECHNICAL CASE REPORT (2008) (18)
Cerebellopontine Angle Craniopharyngioma: Case Report and Literature Review (2007) (18)
Identification of amiodarone in corneal deposits. (1991) (18)
Choroidal (subretinal) neovascularization secondary to choroidal nevus and successful treatment with argon laser photocoagulation. Case reports and review of literature. (1985) (18)
Surgical Exposure of the Sciatic Nerve in the Gluteal Region: Anatomic and Historical Comparison of Two Approaches (2005) (18)
Ultrastructure of the eye in fetal type II glycogenosis (Pompe's disease). (1982) (18)
Phase II study of carboplatin (CBDCA) in progressive low-grade gliomas. (1998) (18)
Identification of distinct and overlapping cortical areas for bilingual naming and reading using cortical stimulation. Case report. (2008) (18)
Severe Adverse Immunologic Reaction in a Patient with Glioblastoma Receiving Autologous Dendritic Cell Vaccines Combined with GM-CSF and Dose-Intensified Temozolomide (2014) (18)
Flexible, high-resolution thin-film electrodes for human and animal neural research (2021) (17)
Exogenous Moraxella liquefaciens endophthalmitis. (1975) (17)
A clinical and histopathological review of intermediate uveitis ("pars planitis"). (1988) (17)
An eclectic history of peripheral nerve surgery. (2004) (17)
Less invasive transjugular approach with Fallopian bridge technique for facial nerve protection and hearing preservation in surgery of glomus jugulare tumors (2013) (17)
Intrathecal Busulfan Treatment of Human Neoplastic Meningitis in Athymic Nude Rats (2004) (17)
PRIMARY SPINAL INTRAMEDULLARY ADRENAL CORTICAL ADENOMA ASSOCIATED WITH SPINAL DYSRAPHISM: CASE REPORT (2006) (17)
Attitudes and opinions of US neurosurgical residents toward research and scholarship: a national survey. (2019) (17)
Perioperative Management of Aneurysmal Subarachnoid Hemorrhage: Part 1. Operative Management (1995) (17)
Three-dimensional Computed Tomographic Analysis of the Relationship Between the Arcuate Eminence and the Superior Semicircular Canal (2006) (17)
LOCALIZATION OF IMMUNOGLOBULINS IN CHRONIC THYROIDITIS. (1964) (17)
Tentorial detachment technique in the combined petrosal approach for petroclival meningiomas. (2012) (17)
Acquired subretinal flecks secondary to hypovitaminosis A in a patient with hepatitis C (2004) (17)
An unusual presentation of isolated optic nerve sarcoidosis. (1983) (16)
Phase II study of Cloretazine for the treatment of adults with recurrent glioblastoma multiforme. (2007) (16)
Ocular pathology of Fabry's disease in a hemizygous male following renal transplantation. (1982) (16)
Neurosurgery DREZ lesions for relief of pain related to spinal cord injury J. Neurosurg., 65 (1986) 465–469 (1987) (16)
History of awake mapping and speech and language localization: from modules to networks. (2019) (16)
Vascular malformations presenting as spinal cord neoplasms: case report. (1995) (16)
Fourth Ventricular Schwannoma: Identical Clinicopathologic Features as Schwann Cell-Derived Schwannoma with Unique Etiopathologic Origins (2011) (15)
A brief history of surgery for peripheral nerve sheath tumors. (2007) (15)
Removal of intravitreous cysticerci from the surface of the optic nervehead. A pars plana approach. (1980) (15)
An eclectic review of the history of peripheral nerve surgery. (2009) (15)
Role of Computed Tomography in the Radiological Evaluation of Painful Radiculopathy after Negative Myelography: Foraminal Neural Entrapment (1984) (15)
Combined microsurgical and endovascular treatment of a giant left middle cerebral artery aneurysm (2010) (15)
Pituitary adenoma presenting as facial pain: report of two cases and review of the literature. (1982) (15)
Choroidal lesions in patients with AIDS. (1990) (15)
Epithelial implantation membrane on the iris surface following cataract extraction with report of two cases. (1971) (15)
Ipsilateral subcortical atrophy associated with temporal lobectomy (1994) (14)
Current Options for the Treatment of Neoplastic Meningitis (2002) (14)
Diagnosis and management of orbital tumors (1990) (14)
Retinal oxalosis in two diabetic patients. (1974) (14)
Fukushima's microanatomy and dissection of The temporal Bone : for surgery of acoustic neuroma, and petroclival meningioma (2007) (14)
Successful treatment of cryptococcal ventriculoatrial shunt infection with systemic therapy alone. (1988) (14)
Middle infratemporal fossa less invasive approach for radical resection of parapharyngeal tumors: surgical microanatomy and clinical application (2015) (13)
Phase II study of bevacizumab plus erlotinib for recurrent malignant gliomas. (2009) (13)
Lateralized seizure termination: relationship to outcome following anterior temporal lobectomy (2001) (13)
Microsurgical resection of vestibular schwannomas: complication avoidance (2016) (13)
Granuloma pyogenicum of the palpebral conjunctiva. (1971) (13)
Extraocular muscle involvement in idiopathic primary amyloidosis. (1971) (13)
Principles and practice of ophthalmology (1984) (13)
Analysis of DNA mismatch repair proteins in human medulloblastoma. (1998) (13)
Diagnosis of phacoanaphylactic endophthalmitis by fine needle aspiration biopsy. (1999) (13)
Intractable epilepsy following radiosurgery for arteriovenous malformation. (2001) (13)
Simian virus 40-induced retinopathy in the rat. (1973) (13)
Eyelid healing after carbon dioxide laser skin resurfacing: histological analysis. (1999) (13)
Castleman's disease confined to the leptomeninges. (2000) (13)
Benign Tumors of the Peripheral Nerve (2011) (13)
CHALLENGES AND OPPORTUNITIES FOR RECRUITING A NEW GENERATION OF NEUROSURGEONS (2007) (13)
Phase II study of bevacizumab and erlotinib in patients with recurrent glioblastoma multiforme (2008) (13)
Myxopapillary Ependymoma and Fatty Filum in an Adult with Tethered Cord Syndrome: A Shared Embryological Lesion? Case Report (2005) (13)
Tamsulosin and the intraoperative floppy iris syndrome. (2009) (12)
Asymptomatic transient uveitis in children with inflammatory bowel disease. (1979) (12)
Oncolytic polio/rhinovirus recombinant (PVSRIPO) against recurrent glioblastoma (GBM): Optimal dose determination. (2015) (12)
Evaluation and Surgical Repair of Brachial Plexus Injuries (2001) (12)
Tumor resection cavity administered iodine-131-labeled antitenascin 81C6 radioimmunotherapy in patients with malignant glioma: neuropathology aspects. (2007) (12)
Unilateral hypoglossal nerve palsy caused by an intraneural ganglion cyst. (2010) (11)
Foreign body reaction to rubber Torkildsen catheters: a report of two cases. (1985) (11)
Shadow cells in an intracranial dermoid cyst. (1995) (11)
Sclero-cornea and defective mesodermal migration (1975) (11)
The retina in type 5 hyperlipoproteinemia. (1976) (11)
Timing of symptomatic vasospasm in aneurysmal subarachnoid hemorrhage: the effect of treatment modality and clinical implications. (2010) (10)
ONCOLYTIC POLIO/RHINOVIRUS RECOMBINANT (PVSRIPO) IN RECURRENT GLIOBLASTOMA (GBM): FIRST PHASE I CLINICAL TRIAL EVALUATING THE INTRATUMORAL ADMINISTRATION (2014) (10)
Surgical anatomy of the carpal tunnel. (1997) (10)
Active cytomegalovirus particles in the eyes of an AIDS patient being treated with 9-[2-hydroxy-1-(hydroxymethyl) ethoxymethyl] guanine (Ganciclovir). (1988) (10)
Racemose (cirsoid) hemangioma in rhesus monkey retina. (1972) (10)
Improved survival in the largest national cohort of adults with cerebellar versus supratentorial low-grade astrocytomas. (2013) (10)
Introduction: peripheral nerve surgery--biology, entrapment, and injuries. (2009) (10)
Retinal dysfunction as an initial ophthalmic sign in AIDS. (1990) (10)
Phase II study of bevacizumab and etoposide in patients with recurrent malignant glioma (2008) (10)
Exophytic syrinx, an extreme form of syringomyelia: CT, myelographic, and MR imaging features. (1992) (10)
Single‐institution retrospective review of patients with recurrent glioblastoma treated with bevacizumab in clinical practice (2019) (10)
Transient open-angle glaucoma associated with sickle cell trait: report of 4 cases. (1979) (10)
Case report. Steroid exophthalmos. (1981) (10)
AT-21FINAL RESULTS OF A PHASE 1 TRIAL OF AN ONCOLYTIC POLIO/RHINOVIRUS RECOMBINANT (PVSRIPO) AGAINST RECURRENT GLIOBLASTOMA (GBM) (2014) (10)
Brachial plexus compression by venous aneurysms. Case illustration. (1997) (9)
Clinical Studies in Non-chromosome 4-Linked Facioscapulohumeral Muscular Dystrophy (2001) (9)
Immunotherapy against angiogenesis-associated targets: evidence and implications for the treatment of malignant glioma (2008) (9)
Safety and efficacy of the addition of bevacizumab (BV) to temozolomide (TMZ) and radiation therapy (RT) followed by BV, TMZ, and irinotecan (CPT-11) for newly diagnosed glioblastoma multiforme (GBM). (2009) (9)
Cerebral hemorrhage and edema following brain biopsy in rats: significance of mean arterial blood pressure. (2000) (9)
Convection-enhanced delivery. (2011) (9)
Rare Lesions of the Internal Auditory Canal. (2017) (9)
Iridogoniodysgenesis with cataract. (1971) (9)
Hemangiopericytoma of the sciatic nerve. Case report. (1991) (8)
ASYMPTOMATIC TRANSIENT UVEITIS IN CHILDREN WITH INFLAMMATORY BOWEL DISEASE (1977) (8)
Progressive outer retinal necrosis. (1995) (8)
Nonarteritic Anterior Ischemic Optic Neuropathy Associated With Acute Glaucoma Secondary to Posner-Schlossman Syndrome (2003) (8)
Congenitally absent C-7 pedicle presenting as a jumped locked facet. Case illustration. (2003) (8)
Predisciform senile macular degeneration. (1973) (8)
Erosion of the orbital plate (frontal bone) by a benign tumor of the lacrimal gland. (1981) (8)
Corneal stromal overgrowth after cataract extraction. (1970) (8)
Photodynamic treatment in a rabbit model of glaucoma surgery. (2003) (8)
Fibrosarcoma of the heart metastatic to the brain. (1983) (7)
Primary myxoma of the parafalcine meninges. Case report. (2006) (7)
Surgical management of nonvascular lesions around the oculomotor nerve. (2014) (7)
Masson's tumor of the pineal region: case report. (2017) (7)
Chemopotentiation by Ultrafractionated Radiotherapy in Glioblastoma Resistant to Conventional Therapy (2010) (7)
Awake craniotomy for malignant glioma resection (2004) (7)
Extradural Dermoid Cyst of the Anterior Infratemporal Fossa. Case Report (2015) (7)
Ocular pathology: A text and atlas, 2nd edition (1982) (7)
Ocular involvement in congenital leukemia. (1986) (7)
Viral particles in the conjunctiva of a patient with the acquired immune deficiency syndrome. (1987) (7)
A phase III randomized prospective trial of external beam radiotherapy, mitomycin C, carmustine, and 6-mercaptopurine for the treatment of adults with anaplastic glioma of the brain. CNS Cancer Consortium. (1996) (7)
Repair of Isolated Axillary Nerve Lesions after Infraclavicular Brachial Plexus Injuries: Case Reports (1990) (7)
Acute toxicity analysis of patients receiving surgery, Gliadel wafer implantation, and postoperative daily temozolomide with radiation therapy for primary high-grade glioma. (2006) (7)
Craniotomy flap osteomyelitis: a diagnostic approach. (1987) (7)
The use of motor mapping to aid resection of eloquent gliomas. (2012) (7)
Does midline shift predict postoperative nausea in brain tumor patients undergoing awake craniotomy? A retrospective analysis (2013) (7)
Hypopyon and iris necrosis in angle-closure glaucoma. Report of two cases. (1972) (7)
ONCOLYTIC POLIOVIRUS IMMUNOTHERAPY OF GLIOBLASTOMA (2014) (7)
Solitary Eosinophilic Granuloma Invading the Clivus of an Adult (1992) (7)
Primary orbital angiomatous meningioma. (2003) (7)
Ocular manifestations of hematologic disorders. (1984) (7)
Retinal pigment epithelial degeneration, partial retinal atrophy and macular hole in acute lymphocytic leukemia (2004) (7)
The status of dorsal root entry zone lesions in 1987. (1989) (7)
Carpal Tunnel Release: Surgical Considerations (2000) (6)
Diagnosis and management of uveitis: An atlas approach (1982) (6)
Comparison of postoperative nausea between benign and malignant brain tumor patients undergoing awake craniotomy: a retrospective analysis (2013) (6)
Coats' disease in a renal transplant recipient. (1987) (6)
Persistent Hyperplastic Primary Vitreous. A Clinicopathologic Study of 62 Cases and Review of the Literature (1978) (6)
A phase I study of sunitinib plus irinotecan in the treatment of patients with recurrent malignant glioma. (2009) (6)
Midsubtemporal Ridge as a Predictor of the Lateral Loop Formed by the Maxillary Nerve and Mandibular Nerve: A Cadaveric Morphological Study (2011) (6)
Diagnosis and management of intraocular tumors (1983) (6)
Orbital phlebography in the study of cavernous sinus disease. (1973) (6)
Management of malignant tumors of the anterior skull base: experience with 76 patients. (2002) (6)
Guppy et al. report a single case of a cerebral infection (1998) (6)
Peripheral Nerve Repair with Collagen Tubes (1992) (6)
Ophthalmic pathology: An atlas and textbook, third edition (1990) (6)
The Melanoma Controversy. A Comparison of Choroidal, Cutaneous, and Iris Melanomas (1981) (5)
Pneumocystis carinii choroiditis after long-term aerosolized pentamidine therapy. (1991) (5)
Endogenous Klebsiella endophthalmitis: case report. (1989) (5)
Combination of bevacizumab, a monoclonal antibody to vascular endothelial growth factor (VEGF), and temozolomide: Study of cases. (2006) (5)
Xanthogranuloma of the sciatic nerve: case report. (2004) (5)
[abstract] TREATMENT OF NEUROLOGICAL SYMPTOMS OF RADIONECROSIS OF THE BRAIN WITH HYPERBARIC OXYGEN: A CASE SERIES. (2002) (5)
Eosinophil chemotaxis and anterior uveitis from topical dimaprit and nordimaprit. (1986) (5)
Ocular manifestations of the acquired immunodeficiency syndrome (1993) (5)
Long-Term Outcomes for Patients With Atypical or Malignant Meningiomas Treated With or Without Radiation Therapy: A 25-Year Retrospective Analysis of a Single-Institution Experience (2021) (5)
Myxopapillary ependymoma and fatty filum in an adult with tethered cord syndrome: a shared embryological lesion? Case report. (2005) (5)
Giant cavernous hemangioma of the face. (1994) (5)
The significance of splenomegaly in 101 adults with acute lymphoblastic leukemia (ALL) at presentation and during remission. (1981) (5)
Phase II trial of Gliadel plus O6-benzylguanine (O6-BG) for patients with recurrent glioblastoma multiforme. (2006) (5)
Asthma in pregnancy; a report of seven cases. (1957) (5)
MGMT: Immunohistochemical Detection in High-Grade Astrocytomas (2018) (5)
CLIN-ONGOING CLINICAL TRIALS (2012) (5)
Experience using two CT-guided stereotactic biopsy methods. (1983) (4)
Lacrimal gland abscess in a child as a rare manifestation of IgG4-related disease. (2017) (4)
Phase II trial of iodine 131-labeled murine anti-tenascin monoclonal anti-body 81C6 (M81C6) via surgically created resection cavity in the treatment of patients with recurrent malignant brain tumors. (2004) (4)
849 Microsurgical Management of Cerebellopontine Angle Epidermoid Tumors: Operative Technique and Results in 152 Cases. (2005) (4)
Comprar Photo Atlas of Skull Base Dissection. Techniques and Operative Approaches | Takanori Fukushima | 9781588905215 | GEORG THIEME (2009) (4)
DREZ Lesions for Treatment of Pain (1997) (4)
Phase I trial of vendetanib and oral etoposide for recurrent malignant gliomas. (2009) (4)
Unusual chorioretinal degeneration associated with sarcoidosis. (1988) (4)
NEURO/MEDICAL ONCOLOGY (2013) (4)
ATIM-27. TUMOR MUTATIONAL BURDEN PREDICTS RESPONSE TO ONCOLYTIC POLIO/RHINOVIRUS RECOMBINANT (PVSRIPO) IN MALIGNANT GLIOMA PATIENTS: ASSESSMENT OF TRANSCRIPTIONAL AND IMMUNOLOGICAL CORRELATES (2019) (4)
Vascular malformations presenting as spinal cord neoplasms (1995) (4)
Traumatic Injury of Neck & Intracranial Vessels (1990) (4)
Dose-finding and safety study of an oncolytic polio/rhinovirus recombinant against recurrent glioblastoma. (2013) (4)
Building a Pulmonary Embolism lysis Practice (4)
The addition of bevacizumab to temozolomide and radiation therapy followed by bevacizumab, temozolomide, and oral topotecan for newly diagnosed glioblastoma multiforme (GBM). (2012) (4)
T-cell lymphoblastic lymphoma involving the ocular adnexa: report of two cases and review of the current literature (2018) (4)
IT-34PILOT STUDY OF COMBINATION OF ANTITUMOR IMMUNOTHERAPY TARGETED AGAINST CYTOMEGALOVIRUS (CMV) PLUS REGULATORY T-CELL INHIBITION IN PATIENTS WITH NEWLY-DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM) (2014) (3)
On angiomas of retina, brain, and skin. (1981) (3)
Senile macular degeneration: clinical, histopathological, and ultrastructural studies. (1980) (3)
Phase 1 single-center, dose escalation study of D2C7-IT administered intratumorally via convection-enhanced delivery for adult patients with recurrent malignant glioma. (2017) (3)
White Matter Tracts (2016) (3)
Dorsal Root Entry Zone Lesions for the Treatment of Post-Brachial Plexus Avulsion Injury Pain (1990) (3)
N-3-pyridylmethyl-N'-p-nitrophenylurea ocular toxicity in man and rabbits. (1988) (3)
Diffuse Astrocytoma (2020) (3)
IMMU-26. SAFETY AND EFFICACY OF PVSRIPO IN RECURRENT GLIOBLASTOMA: LONG-TERM FOLLOW-UP AND INITIAL MULTICENTER RESULTS (2021) (3)
Ocular effects in acquired immune deficiency syndrome. (1983) (3)
Ophthalmic findings in a patient with CD8-positive T cell lymphoma and a hydroa vacciniforme-like eruption (2010) (3)
Newer Antimicrobials for Neurosurgery: Part II: Current Treatment Guidelines (2002) (3)
Phase I study of vandetanib, imatinib mesylate, and hydroxyurea for recurrent malignant glioma. (2009) (3)
Morphological Effects of Angiotensin in Arteries (1974) (3)
Hypertensive crisis with massive retinal and choroidal infarction: A case update (2018) (3)
Phase I study of BCNU and intravenous 6-mercaptopurine in patients with anaplastic gliomas (2004) (3)
Autograft-derived spinal cord mass in the cervical spine following transplantation with olfactory mucosa cells for traumatic spinal cord injury: case report. (2020) (3)
Syringomyelia in a man with sarcoidosis. (1986) (3)
An Eclectic Review of the History of Peripheral Nerve Surgery. (2009) (3)
Role of computed tomography in the radiological evaluation of painful radiculopathy after negative myelography: foraminal neural entrapment. (1984) (3)
Restarting Therapeutic Anticoagulation After Elective Craniotomy for Patients with Chronic Atrial Fibrillation: A Review of the Literature. (2020) (3)
Hyperbaric Oxygen Treatment of Postoperative Neurosurgical Infections. Commentaries (2008) (3)
IMMUNOTHERAPY/BIOLOGICAL THERAPIES (2013) (3)
Oncolytic polio/rhinovirus recombinant (PVSRIPO) against WHO grade IV malignant glioma (MG): Experience with retreatment of survivors from the phase I trial. (2019) (3)
Aicardi syndrome in a 20-year-old female☆ (2018) (2)
Astrocytoma of the spinal cord (2006) (2)
Phase I trial of D2C7 immunotoxin (D2C7-IT) administered intratumorally via convection-enhanced delivery (CED) for recurrent malignant glioma (MG). (2020) (2)
Radiotherapy, Temozolomide and Bevacizumab followed by Irinotecan, Temozolomide and Bevacizumab Appears Well-tolerated and Efficacious in Newly Diagnosed Glioblastoma Multiforme: Results from a Phase II Trial (2009) (2)
Long Term Response in a Patient with Neoplastic Meningitis Secondary to Melanoma Treated with 131 I-Radiolabeled Antichondroitin Proteoglycan (2001) (2)
Masson's tumor presenting as a left frontal intraparenchymal hemorrhage resulting in severe expressive aphasia during pregnancy: case report. (2019) (2)
Alpha1-adrenergic blockers and intraoperative floppy-iris syndrome. (2009) (2)
ATIM-18. PHASE I DOSE ESCALATION STUDY OF D2C7-IT ADMINISTERED INTRATUMORALLY VIA CONVECTION-ENHANCED DELIVERY (CED) FOR RECURRENT MALIGNANT GLIOMA (MG) (2016) (2)
A lost contact lens and Actinomyces colonization in an asymptomatic patient. (2000) (2)
Diagnosis and Management of Hyponatremia in Neurosurgical Patients (2007) (2)
Infectious Causes of Posterior Uveitis (2008) (2)
Surgery for Spasmodic Torticollis (2000) (2)
Retinopathy associated with pancreatitis in a child with maple syrup urine disease (1998) (2)
Case 4--1998. Cardiopulmonary bypass and hypothermic circulatory arrest for basilar artery aneurysm clipping. (1998) (2)
Head injuries. Initial evaluation and management. (1983) (2)
Topical conjunctival corticosteroid therapy for malignant atrophic papulosis (Kohlmeier-Degos disease). (1983) (2)
Neurosurgery residency and fellowship education in the United States: 2 decades of system development by the One Neurosurgery Summit organizations. (2021) (2)
Peri-operative Assessment of Cerebellar Masses and the Potential for Cerebellar Cognitive Affective Syndrome: A Review of the Literature. (2020) (2)
Clinico-Pathological Atlas of Congenital Fundus Disorders (1993) (2)
Phase I trial combining SCH 66336 to temozolomide (TMZ) for patients with grade 3 or 4 malignant gliomas (MG). (2009) (2)
HGG-22. PHASE 1b STUDY POLIO VACCINE SABIN-RHINOVIRUS POLIOVIRUS (PVSRIPO) FOR RECURRENT MALIGNANT GLIOMA IN CHILDREN (2018) (2)
Phase I trial of temozolomide plus O6-benzylguanine on three different 5-day temozolomide regimens for patients with progressive glioblastoma multiforme (2008) (2)
CTIM-23. A PHASE 1 TRIAL OF D2C7-IT IN COMBINATION WITH ATEZOLIZUMAB IN RECURRENT WHO GRADE IV MALIGNANT GLIOMA (MG) (2020) (2)
Phase I study of the intratumoral administration of an oncolytic polio/rhinovirus recombinant (PVSRIPO) in recurrent glioblastoma (GBM). (2014) (2)
871 Simvastatin Reduces Vasospasm after Aneurysmal Subarachnoid Hemorrhage: Results of a Pilot Randomized Clinical Trial. (2005) (2)
Atypical Presentation of Uveal and Conjunctival Melanoma in the Anterior Segment (2016) (1)
Acknowledgement of Reviewers 2012 (2013) (1)
CTIM-10. REPRODUCIBILITY OF CLINICAL TRIALS USING CMV-TARGETED DENDRITIC CELL VACCINES IN PATIENTS WITH GLIOBLASTOMA (2021) (1)
Mixed hemangioblastoma and ependymoma collision tumor of the cerebellum. (2017) (1)
A phase 1 trial of D2C7-it in combination with an Fc-engineered anti-CD40 monoclonal antibody (2141-V11) administered intratumorally via convection-enhanced delivery for adult patients with recurrent malignant glioma (MG). (2022) (1)
Long-term survivorship in adult primary glioblastoma: Clinical and neurological outcomes of a large, single-center study. (2014) (1)
Reproducibility of outcomes in sequential trials using CMV-targeted dendritic cell vaccination for glioblastoma. (2022) (1)
Phase II trial for patients with newly diagnosed glioblastoma (GBM) treated with carmustine wafers followed by concurrent radiation therapy (RT), temozolomide (TMZ), and bevacizumab (BV), then followed by TMZ and BV post-RT. (2013) (1)
Nutritional ophthalmology: 2nd edition, by Donald P. McLaren. London, Academic Press, 1980, 438 pp., illus. Price: $77.00 (1982) (1)
The importance of defining light parameters in chronobiological studies. (1984) (1)
14 Transmastoid Approach: Retrolabyrinthine, Translabyrinthine, and Transcochlear Approaches (2009) (1)
Chapter 56 – Brain Metastases from Malignant Melanoma (2005) (1)
Phase I study of combination of antitumor immunotherapy targeted against cytomegalovirus (CMV) plus regulatory T-cell inhibition in patients with newly diagnosed glioblastoma multiforme (GBM). (2015) (1)
Efficacy and immunologic effects of RNA-pulsed dendritic cell vaccines targeting human cytomegalovirus antigens in patients with glioblastoma (2008) (1)
CTIM-18. LUMINOS-101: INITIAL SAFETY AND TOLERABILITY OF PVSRIPO AND PEMBROLIZUMAB COMBINATION THERAPY IN RECURRENT GLIOBLASTOMA (2021) (1)
Uveitis, fundamentals and clinical practice (1996) (1)
Patients with Malignant Glioma CD 4 Compartment Explains Cellular Immune Defects in Increased Regulatory T-Cell Fraction Amidst a Diminished (2006) (1)
Neurosurgical management of petrous bone lesions: classification system and selection of surgical approaches (2021) (1)
16 Postauricular Transmastoid Posterior Infratemporal Fossa Transjugular Approach (2009) (1)
CLIN-IMMUNOTHERAPY/BIOLOGIC THERAPIES (2012) (1)
9 Frontotemporal Orbitozygomatic Transcavernous Approach (2009) (1)
Screening indices for cytomegalovirus retinitis in patients with human immunodeficiency virus. (1992) (1)
107 Dose-Finding and Safety Study of an Oncolytic Polio/Rhinovirus Recombinant Against Recurrent Glioblastoma (2013) (1)
12 Middle Fossa Rhomboid Approach (Anterior Petrosectomy) (2009) (1)
Chemosis, proptosis and amaurosis in a 19-year-old male. (1975) (1)
Temozolomide (TMZ) and bevacizumab (BV) as initial treatment for unresectable or multifocal glioblastoma multiforme (GBM). (2009) (1)
Results of a phase II trial with iodine 131-labeled murine antitenascin monoclonal antibody 81C6 (m81C6) via surgically created resection cavities in the treatment of patients with recurrent malignant brain tumors (2004) (1)
Report of a Case and Histopathologic Analysis (2017) (1)
11 Preauricular Transzygomatic Approach to the Anterior Infratemporal Fossa and Middle Infratemporal Fossa (2009) (1)
Regulatory T-cell inhibition plus antitumor immunotherapy targeted against cytomegalovirus (CMV) in patients with newly diagnosed glioblastoma multiforme (GBM). (2014) (1)
Neurosurgical Management for the House Officer (1984) (1)
ATIM-24. DOSE FINDING AND DOSE EXPANSION TRIAL OF D2C7 IMMUNOTOXIN (D2C7-IT) ADMINISTERED INTRATUMORALLY VIA CONVECTION-ENHANCED DELIVERY (CED) FOR RECURRENT MALIGNANT GLIOMA (MG) (2019) (1)
Petrous bone lesions: surgical implementation and outcomes of extradural subtemporal approach (2021) (1)
Novel Hormone Receptors Present in Apocrine Cystadenoma of the Eyelid. (2017) (1)
GENETIC-ASPECTS OF INTRACRANIAL ANEURYSMS AND SAH (1994) (1)
Single-institution retrospective review of newly diagnosed glioblastoma (GBM) patients (pts) treated on bevacizumab (BEV) in clinical practice. (2014) (1)
Dose finding study of the intratumoral administration of the oncolytic polio/rhinovirus recombinant (PVSRIPO) against WHO grade IV malignant glioma (MG). (2017) (1)
A phase III randomized prospective trial of external beam radiotherapy (ERT), mitomycin C (MITO), BCNU, and 6-mercaptopurine (6-MP) for the treatment of adults with anaplastic glioma of the brain (1994) (1)
Newer Anticonvulsants for Neurosurgery (2002) (1)
ATIM-36. DOSE ESCALATION TRIAL OF D2C7 IMMUNOTOXIN (D2C7-IT) ADMINISTERED INTRATUMORALLY VIA CONVECTION-ENHANCED DELIVERY (CED) FOR RECURRENT MALIGNANT GLIOMA (MG) (2018) (1)
Recombinant polio-rhinovirus immunotherapy for recurrent paediatric high-grade glioma: a phase 1b trial. (2023) (0)
19 Transcondylar Transtubercular Approach (2009) (0)
De Novo Formation of Familial Cerebral Aneurysms: Case Report (1999) (0)
Newer Antimicrobials for Neurosurgery: Part I: Recently Introduced Agents (2002) (0)
Book reviewOcular Pathology: Fourth Edition, by Myron Yanoff, MD, and Ben S. Fine, MD, St. Louis, Mosby-Year Book, 1996, 732 pp., illus. Price: $210.00 (1996) (0)
Xanthogranuloma of the Sciatic Nerve: Case Report (2004) (0)
AT-20SINGLE INSTITUTION RETROSPECTIVE REVIEW OF PERFORMANCE STATUS AND CORTICOSTEROID USE IN NEWLY DIAGNOSED GLIOBLASTOMA (GBM) PATIENTS (PTS) TREATED ON BEVACIZUMAB (BEV) (2014) (0)
Management of Multiple Cervical Disc Herniations In Patients With Predominant Axial Neck Pain (2010) (0)
Tinzaparin prophylaxis against thromboembolic complications in brain tumor patients. (2006) (0)
Theassociation ofretinitis pigmentosa withpreretinal macular gliosis (1977) (0)
Phase 2 trial of BCNU plus irinotecan in adults with malignant glioma 1 (2004) (0)
17 Total Petrosectomy with Partial Clivectomy (2009) (0)
Theassociation ofrubeosis iridis withendothelialisati (1977) (0)
Subarachnoid haemorrhage: By R.P. Sengupta and V.L. McAllister. 390 pages. $135.00 Berlin: Springer-Verlag, 1986 (1988) (0)
Factors Affecting Patient Outcomes of Atypical Meningiomas in a Modern Cohort (2015) (0)
Subretinal neovascularisati on inocular toxoplasmosis (1982) (0)
How I do it: total resection of a giant sphenoclinoidal meningioma with normalization of near blind vision (2021) (0)
[abstract] HYPERBARIC OXYGEN FOR THE TREATMENT OF RADIONECROSIS OF THE BRAIN. (2000) (0)
Variant of the Epidermal Growth Factor Receptor , EGFRvIII Cell Surface Localization and Density of the Tumor-associated Updated (2006) (0)
A Bispecific Tandem ScFv Recruits Immune Cells to Treat Established Intracranial Tumors in Mice Implanted with Orthotopic EGFRvIII-expressing Human Glioma Xenograft. (2011) (0)
Pathologie des auges (1981) (0)
Preoperative Functional MR Imaging Localization of Language and Motor Areas: EffectonTherapeuticDecisionMaking inPatientswithPotentiallyResectable (2006) (0)
Obituary. Robert H. Wilkins, MD, 1934-2017. (2017) (0)
Histopathologic Findings in Intraoperative Floppy Iris Syndrome (IFIS) (2009) (0)
Impact of Tumor Histology on Resectability and Neurologic Outcomes in Primary Intramedullary Spinal Cord Tumors (2010) (0)
Lower Extremity Pain Caused by Cervical Stenosis (1987) (0)
Safety and efficacy of the addition of bevacizumab to temozolomide and radiation therapy followed by bevacizumab, temozolomide, and irinotecan for newly diagnosed glioblastoma multiforme. (2012) (0)
Phase II Trial of Gliadel plus O 6-Benzylguanine in Adults with Recurrent GlioblastomaMultiforme (2009) (0)
Delayed Mustard Keratitis in Northern Iraq (2010) (0)
Uveitis and infectious diseases: Editorial overview (1992) (0)
Fabry's disease. (1972) (0)
Development of a thermally responsive peptide for sustained deliver of solyble TNF receptor II to attenuate inflammatory events associated with radiculopathys (2007) (0)
MR imaging in patients with temporal lobe seizures: correlation of results with pathologic findings. (1990) (0)
Irinotecan T herapy i n A dults W ith R ecurrent o r P rogressive Malignant G lioma (1999) (0)
SM-02LEVETIRACETAM USAGE IN POST-OPERATIVE SEIZURE MANAGEMENT IN MALIGNANT GLIOMA (2014) (0)
Multicenter P hase I I T rial o f T emozolomide i n P atients With A naplastic A strocytoma o r A naplastic Oligoastrocytoma a t F irst R elapse (1999) (0)
Astrocytoma of the brainstem (2006) (0)
Alterations of the TP 53 Gene in Human ( Â ¿ liornas 1 (2006) (0)
AT-22PHASE II TRIAL OF BEVACIZUMAB, RADIATION THERAPY (RT) AND TEMOZOLOMIDE FOLLOWED BY BEVACIZUMAB AND TEMOZOLOMIDE WITH CONTINUATION OF BEVACIZUMAB BEYOND PROGRESSION (2014) (0)
2 Transmaxilloethmoidal Approach (2009) (0)
Advances in Brief PTEN Gene Mutations Are Seen in High-Grade but not in Low-Grade Gliomas 1 (2006) (0)
3 Transfacial Transmaxillary Approach (2009) (0)
ATCT-13BEVACIZUMAB, RADIATION THERAPY (RT) AND TEMOZOLOMIDE FOLLOWED BY BEVACIZUMAB AND TEMOZOLOMIDE WITH CONTINUATION OF BEVACIZUMAB BEYOND PROGRESSION: A PHASE II TRIAL (2015) (0)
Surgical Management of Intracranial Epidermoid Tumors. Lessons Learned from 334 Cases Over 3 Decades (2017) (0)
Research Update in Neuroscience for Neurosurgeons: a historical perspective. (2019) (0)
Foundations of ophthalmic pathology (1980) (0)
CLIN-NEURO/MEDICAL ONCOLOGY (2012) (0)
CASTLEMANʼS DISEASE (PLASMA CELL VARIANT) CONFINED TO THE LEPTOMENINGES (1996) (0)
ATIM-31. SAFETY OF TUMOR-SPECIFIC PEPTIDE VACCINE TARGETING ISOCITRATE DEHYDROGENASE 1 MUTATION IN RECURRENT RESECTABLE LOW GRADE GLIOMA PATIENTS (2019) (0)
Traumatic Transverse Process Fractures: A Clinical Overview (2012) (0)
Eosinophilic globules in a classic ependymoma: evidence of a possible secretory role (2020) (0)
Surgical Management of Vestibular Schwannomas after Failed Radiation (2013) (0)
Book reviewPeter Watson, Joseph M. Ortiz, Color Atlas of Scleritis, Mosby-Wolfe, London (1995), 122 pp., illus. Price: $74.00 (1996) (0)
Primary Central Nervous System Lymphoma: Lessons for the Neurosurgeon Part II: Staging and Treatment (2010) (0)
815 Troponin Trend Can Differentiate “Stunned” Myocardium Associated with Aneurysmal Subarachnoid Hemorrhage vs. Myocardial Infarction (2001) (0)
Forty-second Annual Meeting of the Southern Neurosurgical Society, Key West, Florida, March 30-April 1, 1990 (1990) (0)
Hypopyon andiris necrosis in angle-closure glaucoma Report oftwocases (1972) (0)
Ocular pathology update (1981) (0)
DEVELOPMENT OF A NON-INVASIVE MONITOR FOR DETERMINING BODY FLUID PARTITIONING IN HUMANS (1992) (0)
Atypical Central Neurocytoma Confined to the Third Ventricle: Case Report and Systematic Review of the Literature (2019) (0)
Neurotization of the Upper Extremity: Technique (2000) (0)
Surgery for Stroke (1995) (0)
vacciniforme-like eruption CD 8-positive T cell lymphoma and a hydroa Ophthalmic findings in a patient with (2010) (0)
5 Endonasal Paraseptal Transsphenoidal Approach (2009) (0)
Ocular pathology: A text and atlas, third edition: by Myron Yanoff, M.D. and Ben S. Fine, M.D., Philadelphia, J.B. Lippincott, 1989, 737 pp., illus. Price: $95.00 (1990) (0)
Persistent Hyperplastic Primary Vitreous (1993) (0)
Primary Central Nervous System Lymphoma: Lessons for the Neurosurgeon Part I: Diagnosis (2010) (0)
Complications After Glioma Surgery (2019) (0)
Intracranial aneurysms for the primary care physician. (1987) (0)
BILOGIC PRINCIPLES AND MODERN PRACTICE OF OBSTERTICS (1975) (0)
Electron microscopic observations of intravitreal Cysticercus cellulosae (Taenia solium). (1980) (0)
An Appreciation (1973) (0)
Sexually transmitted ocular disorders associated with male homosexuality. (1987) (0)
13 Anatomy for Posterolateral Skull Base Surgery (2009) (0)
CSF ISOFLURANE UPTAKE AND ELIMINATION IN HUMANS (1992) (0)
ANTERIOR TEMPORAL LOBECTOMY IN PATIENTS WITH MRI EVIDENCE OF BILATERAL HIPPOCAMPAL SCLEROSIS (1995) (0)
Contents, Vol. 192, 1986 (1986) (0)
18 Anatomy for Posterior Skull Base Surgery (2009) (0)
NEURO-BEHCET'S DISEASE IN JAPAN. AUTHORS' REPLY (1996) (0)
Uveitis and infectious diseases (1992) (0)
1 Craniofacial Anatomy (2009) (0)
20 Lateral Suboccipital Approach: Superior, Middle, and Inferior Cerebellopontine Angle Approach (2009) (0)
Colored Temporal Bone Model Created by Additive Manufacturing (2012) (0)
Intraocular tumors: edited by Gholam A. Peyman, David J. Apple, and Donald R. Sanders. New York, Appleton-Century-Crofts, 1977, 382 pp. Price: $32.50 (1979) (0)
Ablative spinal cord surgery for the treatment of chronic pain (1997) (0)
In Memoriam: Robert H. Wilkins, MD, 1934 to 2017. (2017) (0)
The Presence of Pseudoexfoliation Deposits on Intraocular Lenses (2008) (0)
6 Transoral Approach (2009) (0)
In Memoriam: Robert H. Wilkins, MD, 1934 to 2017. (2017) (0)
Phase II study of irinotecan ( CPT-11 ) in children with high-risk malignant brain tumors : The Duke experience 1 (2005) (0)
Subtle cord magnetic resonance changes in cervical myelomalacia. (1986) (0)
Phase II study of bevacizumab plus irinotecan and carboplatin for recurrent WHO grade 3 malignant gliomas with no prior bevacizumab failure. (2012) (0)
8 Anatomy for Anterolateral Skull Base Surgery (2009) (0)
AT-19SINGLE INSTITUTION RETROSPECTIVE COMPARISON OF GLIOBLASTOMA (GBM) PATIENTS (PTS) INITIATED ON BEVACIZUMAB (BEV) BEFORE VERSUS AFTER RECURRENCE IN CLINICAL PRACTICE (2014) (0)
EXTERNAL ENDOMETRIOSIS: THE CLINICAL PROBLEM (1959) (0)
Giant Cavernous Hemangioma of the Face-Reply (1994) (0)
In Memoriam: Steven M. Podos, MD (1937-2009) (2010) (0)
gliosis . pigmentosa with preretinal macular The association of retinitis (2004) (0)
Physicians' Desk Reference for Opbtbalmology: (1974) (0)
10 Anatomy for Lateral Skull Base Surgery (2009) (0)
Validation of an Online Calculator to Predict Short-term Postoperative Outcomes in Patients with Metastatic Brain Tumors (2021) (0)
Phase I I T rial o f T emozolomide i n P atients W ith P rogressive Low-Grade G lioma (2003) (0)
4 Bifrontal Transbasal Approach (2009) (0)
Neurophysiological intraoperative monitoring of the glossopharyngeal nerve (2008) (0)
Diagnosis and treatment of IgG4-related ophthalmic disease (2015) (0)
EXTRACELLULAR MATRIX ANTIGENS IN CAPILLARY HEMANGIOBLASTOMA (1997) (0)
ATIM-27. INTRATUMORAL ADMINISTRATION OF AN ONCOLYTIC POLIO/RHINOVIRUS RECOMBINANT (PVSRIPO) IN MALIGNANT GLIOMA PATIENTS: ASSESSMENT OF MUTATIONAL RESPONSE CORRELATES (2018) (0)
High-Dose C hemotherapy W ith A utologous S tem-Cell R escue in C hildren a nd A dults W ith N ewly D iagnosed P ineoblastomas (2003) (0)
MS-19LONG-TERM OUTCOMES FOR PATIENTS WITH INTRACRANIAL MENINGIOMAS: A SINGLE-INSTITUTION RETROSPECTIVE ANALYSIS (2014) (0)
A PHASE III RANDOMIZED PROSPECTIVE TRIAL OF EXTERNAL BEAM RADKlTHERAPY, MITOMYCIN C, CARMUSTINE, AND 6-~RCA~~NE FOR THE TREATMENT OF ADULTS WITH ANAPLAS'IK GLIOMA OF THE BRAIN (1995) (0)
Retrolabyrinthine transsigmoid approach to complex parabrainstem tumors in the posterior fossa. (2021) (0)
Novel Application of Steroid Eluting Stent in Petrous Apex Cholesterol Granuloma (2018) (0)
15 Combined Petrosal Approach (2009) (0)
Association and chance occurrence of aniridia and retinoblastoma. (1994) (0)
7 Orbital Approach (2009) (0)
Alterations of the TP53 Gene in Human (Â¿liornas1 (2006) (0)
Intracranial aneurysm surgery — Techniques (1991) (0)
Chapter 25 – Ependymoma (2005) (0)
Epidermal Growth Factor Receptor VIII Peptide Vaccination Is Efficacious against Established Intracerebral Tumors 1 (2003) (0)
Abstract 5611: Interleukin-2 receptor α (IL-2R α/CD25)-specific antibodies eliminate regulatory T-cells (TRegs) and enhance tumor-specific immune responses (2010) (0)
Contents, Vol. 190, 1985 (1985) (0)
Clinicopathological correlations in unilateral glaucoma. (1979) (0)
Novel Application of Steroid-Eluting Stent in Petrous Apex Cholesterol Granuloma Approached Endonasally: A Case Series (2018) (0)
Accurate speech decoding requires high-resolution neural interfaces (2022) (0)
High-resolution neural recordings improve the accuracy of speech decoding (2022) (0)
NEIM-03. FEASIBILITY OF AUTOMATED ASSESSMENT OF PROGRESSIVE ENHANCEMENT ON MRI IN PATIENTS WITH NEWLY DIAGNOSED HIGH-GRADE GLIOMA USING A FEATURE-BASED ALGORITHM (2021) (0)
The effect of Propofol versus Isoflurane Anesthesia on Human CSF Markers of Alzheimer ’ s Disease : Results of a Randomized Trial (2015) (0)
BIOM-20. TUMOR-INTRINSIC AND PERIPHERAL FEATURES ASSOCIATE WITH SURVIVAL AFTER POLIO VIROTHERAPY IN RECURRENT GBM (2021) (0)
Abstract CT416: Intratumoral administration of an Oncolytic Polio/Rhinovirus Recombinant (PVSRIPO) in recurrent glioblastoma (GBM): Preliminary results of the Phase I clinical trial (2014) (0)
Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy (2021) (0)
The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma (2018) (0)
Treatment of Neoplastic Meningitis with Intrathecal Temozolomide 1 (2000) (0)
Image-guided Stereotactic Radiotherapy in the Multimodal Treatment of Intracranial Meningiomas at a Single Institution (2010) (0)
Dosimetry of 1311-Labeled81C6 Monoclonal Antibody Administered into Surgically Created Resection Cavities in Patients with Malignant Brain Tumors (2006) (0)
CTIM-15. RESULTS OF A PHASE IB TRIAL OF RECOMBINANT POLIO:RHINOVIRUS IMMUNOTHERAPY FOR RECURRENT PEDIATRIC HIGH GRADE GLIOMA (2022) (0)
Abstract 1177: The mutational status of the p53 tumor suppressor gene is a determinant of GSTP1 expression and mediates GSTP1-dependent drug resistance in human glioblastoma (2012) (0)
Second Case of Tumors Associated With Heterozygous NTHL1 Variant (2022) (0)
Reply from the author: (1995) (0)
CTIM-23. DOSE ESCALATION TRIAL OF FC-ENGINEERED ANTI-CD40 MONOCLONAL ANTIBODY (2141-V11) ADMINISTERED INTRATUMORALLY WITH D2C7-IT VIA CONVECTION-ENHANCED DELIVERY (CED) FOR RECURRENT MALIGNANT GLIOMAS (RMGS) (2022) (0)
Abstract PL07-01: Linkage disequilibrium-based analysis of DNA repair and GST genes in malignant gliomas: A unique tool in defining the association between genetic diversity and survival (2011) (0)
Long-Term Outcomes for Patients With Atypical or Malignant Meningiomas Treated With Radiation Therapy: A Single-Institution Retrospective Analysis (2016) (0)
Indication for a skull base approach in microvascular decompression for hemifacial spasm (2022) (0)

This paper list is powered by the following services:

Other Resources About Allan Friedman

en.wikipedia.org

What Schools Are Affiliated With Allan Friedman?

Allan Friedman is affiliated with the following schools:

Allan Friedman's Academic­Influence.com Rankings

Allan Friedman's Degrees

Why Is Allan Friedman Influential?

Allan Friedman's Published Works

Published Works

Other Resources About Allan Friedman

What Schools Are Affiliated With Allan Friedman?

Allan Friedman's AcademicInfluence.com Rankings